Brief: Emcure Pharmaceuticals Launches Poviztra Semaglutide Injection In India
22/12/2025 06:39
Dec 22 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS: LAUNCHES POVIZTRA SEMAGLUTIDE INJECTION IN INDIA Source text: ID:nBSE3vwLvG Further company coverage: EMCU.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees